‎PureHealth Q2 2026 earnings forecasts

Source: Argaam - UAE News
Source link: https://www.argaam.com/en/article/articledetail/id/1924474
Published: 2026-07-30 12:43:00
Discovered by ProcIntel: 2026-07-31 08:54:00
Category: GCC Spotlight
Geography: UAE
Organisations: —
Review status: Pending
Record type: REAL

Summary

‎<img src="https://argaamplus.s3.amazonaws.com/05e5b960-d2a7-412d-9a23-09cc9678dd29.png" >Pure Health logo <hr> Argaam, in this report, provides an overview of PureHealth expected results for Q2 2026 along with trends in quarterly revenue and earnings, in addition to key operating and profitability indicators. Quarterly Revenue – AED mln <table border="0" cellpadding="0"> <thead> <tr> <th > Item </th> <th > 2Q 2025 </th> <th > 3Q 2025 </th> <th > 4Q 2025 </th> <th > 1Q 2026 </th> <th > 2Q 2026 (Consensus) </th> </tr> </thead> <tbody> <tr> <td > Revenue </td> <td > 6,993.0 </td> <td > 6,527.2 </td> <td > 7,210.8 </td> <td > 7,262.3 </td> <td > 7,352.0 </td> </tr> <tr> <td > Change (%) </td> <td > +9.5% </td> <td > +1.2% </td> <td > +4.6% </td> <td > +10.4% </td> <td > +5.1% </td> </tr> </tbody> </table> Quarterly Earnings– AED mln <table border="0" cellpadding="0"> <thead> <tr> <th > Item </th> <th > 2Q 2025 </th> <th > 3Q 2025 </th> <th > 4Q 2025 </th> <th > 1Q 2026 </th> <th > 2Q 2026 (Consensus) </th> </tr> </thead> <tbody> <tr> <td > Net income </td> <td > 522.3 </td> <td > 520.8 </td> <td > 455.2 </td> <td > 386.6 </td> <td > 394.8 </td> </tr> <tr> <td > Exceptional item </td> <td > 0.0 </td> <td > 0.0 </td> <td > 535.6* </td> <td > 0.0 </td> <td > 0.0 </td> </tr> <tr> <td > Net income before exceptional and non-recurring items </td> <td > 522.3 </td> <td > 520.8 </td> <td > (80.5) </td> <td > 386.6 </td> <td > 394.8 </td> </tr> <tr> <td > EPS excluding non-recurring items (AED/share) </td> <td > 0.05 </td> <td > 0.05 </td> <td > (0.01) </td> <td > 0.03 </td> <td > 0.04 </td> </tr> </tbody> </table> * Operating expense grant income of AED 437.4 million, capital expenditure grant income of AED 43.5 million, reversal of management incentives amounting to AED 42.5 million, and a gain of AED 12.2 million from the disposal of property and equipment. Key events in Q2 2026 Shareholders approved a cash dividend of AED 0.0541 per share for 2025. The company inaugurated a campus for the University of Nicosia in Athens, Greece, in the presence of senior officials. The campus will offer medical education integrating artificial intelligence with clinical training. The initiative aims to strengthen UAE-Greece cooperation, help address Europe's healthcare workforce shortage by linking academic education with scientific research and provide exchange and practical training programs. The company announced that its insurance arm, Daman, received an A1 Insurance Financial Strength Rating from Moody's Ratings with a stable outlook, the highest rating among insurers in the UAE and the GCC. The rating reflects the company's financial strength and the successful transformation of Daman into a comprehensive and sustainable insurance platform. Average forecasts The company is forecast to report a net profit of AED 394.8 million, 24% lower year-on-year (YoY), according to the average estimates of two research houses. Average estimates – AED mln <table border="0" cellpadding="0"> <thead> <tr> <th > Research House </th> <th > Forecast (AED mln) </th> </tr> </thead> <tbody> <tr> <td > FAB Securities </td> <td > 467.0 </td> </tr> <tr> <td > Bank of America </td> <td > 322.6 </td> </tr> <tr> <td > Consensus </td> <td > 394.8 </td> </tr> <tr> <td > Net profit before exceptional and non-recurring items (2Q 2025) </td> <td > 522.3 </td> </tr> <tr> <td > Difference (%) </td> <td > (24%) </td> </tr> </tbody> </table> Stock performance <table border="0" cellpadding="0"> <thead> <tr> <th > Metric </th> <th > Company </th> <th > Market </th> </tr> </thead> <tbody> <tr> <td > Change YTD </td> <td > (12.94%) </td> <td > (1.53%) </td> </tr> <tr> <td > Change over the last 12 months </td> <td > (26.97%) </td> <td > (4.86%) </td> </tr> <tr> <td > Previous close </td> <td > 2.22 </td> <td > 9,839.56 </td> </tr> <tr> <td > Recurring P/E </td> <td > 18.28x </td> <td > 22.39x </td> </tr> <tr> <td > Trailing 12-month EPS excluding non-recurring items (AED/share) </td> <td > 0.121 </td> <td > -- </td> </tr> </tbody> </table> <div ></div>

Procurement Relevance Gate

PASS — score 21.1/100 — evaluated 2026-07-31 08:55:19

Passed on: price_availability_leadtime_demand, geographic_exposure (score 21.1/100, threshold 20.0).

price_availability_leadtime_demand (weight 10) — matched on "shortage"
geographic_exposure (weight 8) — matched on "1 linked geography"

Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.

A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.

Initial Significance: 1 · Low (14.0/100)
Initial Confidence: 2 · Low (39.0/100)
Data sufficiency Whether enough structured evidence exists to trust this Signal's Initial Confidence reading. 'Sufficient' has no cap; 'Partial' and 'Insufficient' cap Confidence until more evidence is available; 'Not Assessed' means the Signal did not pass the Relevance Gate.: Partial
Strongest contributor: Procurement Impact
Limiting factor: Geographic Breadth

Initial Significance Low (14.0/100). Strongest contributor: Procurement Impact (6.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Low (39.0/100, data sufficiency: Partial). Strongest contributor: Source Authority (20.0/40 points). Limiting factor: Extraction Quality (3.0/15 points).

No likely Event type matched; a low contextual baseline was applied.
No eligible (non-geographic, non-fictional) entities were linked to this Signal.
no matched Event type
no actor entities (only attribution/metadata, if any)
no actor content-derived geography
Only source-level entity metadata was available.
Only source-level geography metadata was available.
Source metadata did not contribute to Initial Confidence.

Linked Canonical Event(s): ‎PureHealth Q2 2026 earnings forecasts

Methodology signal_scoring_v1 — calculated 2026-08-03 16:29:55.

‎PureHealth Q2 2026 earnings forecasts

Summary

Procurement Relevance Gate

Initial Signal Assessment ⓘMore about Initial Signal AssessmentProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.

Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.